Estimating correlations between vaccine clinical trial outcomes

© 2021 Informa UK Limited, trading as Taylor & Francis Group.

Bibliographische Detailangaben
Veröffentlicht in:Journal of applied statistics. - 1991. - 49(2022), 13 vom: 30., Seite 3392-3413
1. Verfasser: Rey, Alexey (VerfasserIn)
Weitere Verfasser: Rozanova, Olga, Zhuk, Sergey
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Journal of applied statistics
Schlagworte:Journal Article 62P10 62P20 62Pxx Applications of statistics clinical trials correlations factor models latent variables maximum likelihood
LEADER 01000caa a22002652 4500
001 NLM34729037X
003 DE-627
005 20240905232200.0
007 cr uuu---uuuuu
008 231226s2022 xx |||||o 00| ||eng c
024 7 |a 10.1080/02664763.2021.1949439  |2 doi 
028 5 2 |a pubmed24n1524.xml 
035 |a (DE-627)NLM34729037X 
035 |a (NLM)36213772 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Rey, Alexey  |e verfasserin  |4 aut 
245 1 0 |a Estimating correlations between vaccine clinical trial outcomes 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 05.09.2024 
500 |a published: Electronic-eCollection 
500 |a Citation Status PubMed-not-MEDLINE 
520 |a © 2021 Informa UK Limited, trading as Taylor & Francis Group. 
520 |a We demonstrate how a linear factor model with latent variables can be used to estimate correlations between the outcomes of clinical trials. These correlations are needed for many policy questions of drug/vaccine development (such as calculating the optimal size of financial incentives) and the literature so far has relied on expert opinions. We apply our methodology to the case of vaccines and show that the estimated correlations are highly significant. We also illustrate how the estimated correlations can be used to find the probability of obtaining a successful vaccine out of a certain number of candidates and to determine optimal investment in vaccine development 
650 4 |a Journal Article 
650 4 |a 62P10 
650 4 |a 62P20 
650 4 |a 62Pxx 
650 4 |a Applications of statistics 
650 4 |a clinical trials 
650 4 |a correlations 
650 4 |a factor models 
650 4 |a latent variables 
650 4 |a maximum likelihood 
700 1 |a Rozanova, Olga  |e verfasserin  |4 aut 
700 1 |a Zhuk, Sergey  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Journal of applied statistics  |d 1991  |g 49(2022), 13 vom: 30., Seite 3392-3413  |w (DE-627)NLM098188178  |x 0266-4763  |7 nnns 
773 1 8 |g volume:49  |g year:2022  |g number:13  |g day:30  |g pages:3392-3413 
856 4 0 |u http://dx.doi.org/10.1080/02664763.2021.1949439  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 49  |j 2022  |e 13  |b 30  |h 3392-3413